Table 2 Medications
Variable | IR (+) | IR(-) | p-valuea | NGT | IGT | T2DM5# | p-valuea |
|---|---|---|---|---|---|---|---|
n (%) | 38 (18) | 113 (54) | - | 64 (31) | 54 (26) | 90 (43) | - |
Glucose lowering treatment | |||||||
Metformin, n (%) | 0 (0) | 1 (0.9) | 0.748 | 0 (0) | 1 (2) | 64 (71) | <0.001* |
Sulfonylurea, n (%) | 0 (0) | 1 (0.9) | 0.748 | 0 (0) | 0 (0) | 1 (1) | <0.001* |
Insulin therapy, n (%) | 0 (0) | 0 (0) | - | 0 (0) | 0 (0) | 24 (34) | <0.001* |
Thiazolidinediones, n (%) | 0 (0) | 0 (0) | - | 0 (0) | 0 (0) | 2 (2) | 0.266 |
Glinide, n (%) | 0 (0) | 0 (0) | - | 0 (0) | 0 (0) | 2 (2) | 0.266 |
Hypertension treatment | |||||||
Beta-blocker, n (%) | 23 (61) | 72 (63) | 0.434 | 33 (52) | 39 (72) | 62 (69) | 0.033* |
AT1 receptor blocker, n (%) | 5 (13) | 16 (14) | 1.000 | 9 (14) | 6 (11) | 15 (17) | 0.653 |
ACE-inhibitor, n (%) | 24 (36) | 65 (58) | 0.573 | 31 (48) | 37 (69) | 55 (61) | 0. 076 |
Calcium antagonist, n (%) | 7 (18) | 18 (16) | 0.801 | 9 (14) | 6 (11) | 23 (26) | 0.055 |
Diuretics, n (%) | 12 (32) | 31 (27) | 0.679 | 16 (25) | 16 (30) | 31 (34) | 0.450 |
Other Medications | |||||||
Nitrate, n (%) | 5 (13) | 7 (6) | 0.181 | 1 (2) | 7 (13) | 16 (18) | 0.008* |
Acetyl salicylic acid, n (%) | 24 (63) | 76 (68) | 0.691 | 38 (60) | 40 (74) | 65 (73) | 0.169 |
Clopidrogel, n (%) | 11 (29) | 34 (31) | 1.000 | 13 (21) | 18 (33) | 28 (32) | 0.259 |
Allopurinol, n (%) | 5 (13) | 6 (5.4) | 0.147 | 3 (5) | 3 (6) | 15 (17) | 0.022* |
Aldosterone antagonist, n (%) | 1 (3) | 0 (0) | 0.248 | 0 (0) | 1 (2) | 0 (0) | 0.245 |
Statin, n (%) | 16 (42) | 60 (53) | 0.423 | 27 (42) | 28 (52) | 49 (55) | 0.598 |